Format

Send to

Choose Destination
Eur J Pharmacol. 2009 Jan 5;602(1):101-4. doi: 10.1016/j.ejphar.2008.10.065. Epub 2008 Nov 12.

GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice.

Author information

1
Laboratory of Neuropsychopharmacology, Division of Life Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa 920-1192, Japan.

Abstract

In this study, we investigated the effects of GABA(A) and GABA(B) receptor agonists on the methamphetamine-induced impairment of recognition memory in mice. Repeated treatment with methamphetamine at a dose of 1 mg/kg for 7 days induced an impairment of recognition memory. Baclofen, a GABA(B) receptor agonist, ameliorated the repeated methamphetamine-induced cognitive impairment, although gaboxadol, a GABA(A) receptor agonist, had no significant effect. GABA(B) receptors may constitute a putative new target in treating cognitive deficits in patients suffering from schizophrenia, as well as methamphetamine psychosis.

PMID:
19028488
DOI:
10.1016/j.ejphar.2008.10.065
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center